A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain

Clinical trial NCT04094662 · COMPLETED

Trial details

NCT number: NCT04094662
Sponsor: Daiichi Sankyo Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Peripheral Neuropathic Pain

Start date: 2019-09-18
Primary completion: 2022-01-17
Enrollment: 393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.